Skip to main content
Have a personal or library account? Click to login
Effects of OROS-MPH Versus Dl-Amphetamine-XR on Driving Performance of ADHD Adolescents Cover

Effects of OROS-MPH Versus Dl-Amphetamine-XR on Driving Performance of ADHD Adolescents

Open Access
|Oct 2006

Abstract

Driving performance of 35 adolescent ADHD patients (19 boys/16 girls; mean age 17.8 years) on a driving simulator was compared while taking OROS methylphenidate (Concerta, 72 mg), mixed dl-amphetamine salts (Adderall XR, 30 mg), or placebo in a randomized, double-blind, crossover study at University of Virginia, Charlottesville.
Language: English
Page range: 75 - 76
Published on: Oct 1, 2006
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 2006 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.